GLP-1RAs stimulate insulin secretion in a glucose-dependent manner, therefore, reduce the risk of hypoglycemia
Glucose-reducing effect of the ORMD-0801 oral insulin preparation in patients with uncontrolled type 1 diabetes: a pilot study
lactis helps counteract both issues
These data strongly suggest that GLP-1R agonists are beneficial to attenuate neuroinflammation-associated cognitive impairment and thereby improve cognition
A better understanding of the complex biochemical interactions that regulate metabolic homeostasis in healthy individuals and the altered metabolic phenotype in patients with metabolic disorders will likely lead to the development of more efficacious treatments
Marguet D, Baggio L, Kobayashi T, Bernard AM, Pierres M, Nielsen PF, Ribel U, Watanabe T, Drucker DJ, and Wagtmann N